These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
729 related items for PubMed ID: 12732648
1. Troglitazone antagonizes tumor necrosis factor-alpha-induced reprogramming of adipocyte gene expression by inhibiting the transcriptional regulatory functions of NF-kappaB. Ruan H, Pownall HJ, Lodish HF. J Biol Chem; 2003 Jul 25; 278(30):28181-92. PubMed ID: 12732648 [Abstract] [Full Text] [Related]
2. Troglitazone, a peroxisome proliferator-activated receptor gamma (PPAR gamma ) ligand, selectively induces the early growth response-1 gene independently of PPAR gamma. A novel mechanism for its anti-tumorigenic activity. Baek SJ, Wilson LC, Hsi LC, Eling TE. J Biol Chem; 2003 Feb 21; 278(8):5845-53. PubMed ID: 12475986 [Abstract] [Full Text] [Related]
3. Role of PPAR gamma in regulating adipocyte differentiation and insulin-responsive glucose uptake. Hamm JK, el Jack AK, Pilch PF, Farmer SR. Ann N Y Acad Sci; 1999 Nov 18; 892():134-45. PubMed ID: 10842659 [Abstract] [Full Text] [Related]
9. Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice. Memon RA, Tecott LH, Nonogaki K, Beigneux A, Moser AH, Grunfeld C, Feingold KR. Endocrinology; 2000 Nov 18; 141(11):4021-31. PubMed ID: 11089532 [Abstract] [Full Text] [Related]
10. Expression of NAG-1, a transforming growth factor-beta superfamily member, by troglitazone requires the early growth response gene EGR-1. Baek SJ, Kim JS, Nixon JB, DiAugustine RP, Eling TE. J Biol Chem; 2004 Feb 20; 279(8):6883-92. PubMed ID: 14662774 [Abstract] [Full Text] [Related]
15. Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone. Camp HS, Li O, Wise SC, Hong YH, Frankowski CL, Shen X, Vanbogelen R, Leff T. Diabetes; 2000 Apr 28; 49(4):539-47. PubMed ID: 10871190 [Abstract] [Full Text] [Related]
16. Ligand activation of peroxisome proliferator-activated receptor gamma induces apoptosis of leukemia cells by down-regulating the c-myc gene expression via blockade of the Tcf-4 activity. Yamakawa-Karakida N, Sugita K, Inukai T, Goi K, Nakamura M, Uno K, Sato H, Kagami K, Barker N, Nakazawa S. Cell Death Differ; 2002 May 28; 9(5):513-26. PubMed ID: 11973610 [Abstract] [Full Text] [Related]
17. Peroxisome proliferator-activated receptor γ agonist troglitazone inhibits high mobility group box 1 expression in endothelial cells via suppressing transcriptional activity of nuclear factor κB and activator protein 1. Gao M, Hu Z, Zheng Y, Zeng Y, Shen X, Zhong D, He F. Shock; 2011 Sep 28; 36(3):228-34. PubMed ID: 21617575 [Abstract] [Full Text] [Related]
18. Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma. Wang M, Wise SC, Leff T, Su TZ. Diabetes; 1999 Feb 28; 48(2):254-60. PubMed ID: 10334298 [Abstract] [Full Text] [Related]